BioPort 2018, Atlantic Canada’s largest health and life sciences industry conference, is set to explore trends transforming the industry in Halifax, November 7 & 8, 2018.
This year’s conference will focus on The Future of Health, with sessions covering the impact of new technology on health and the value of the emerging medical cannabis market.
The Conference, hosted by our friends at BioNova, attracts health and life sciences innovators, industry leaders, and investors from across North America and will take place November 7-8, 2018 at the Halifax Convention Centre, in Halifax, Nova Scotia.
“BioPort provides a venue to highlight the accelerating momentum of the global health and life sciences sector, providing expert perspectives on opportunities and showcasing some of Atlantic Canada’s most ground-breaking, bio-focused entrepreneurs,” said Andy Fillmore, Parliamentary Secretary to the Minister of Canadian Heritage and Multiculturalism and Member of Parliament for Halifax.
“From foundational research to new disruptive innovations coming to market, BioPort creates the right conditions to build on Atlantic Canada’s unique strengths in biotechnology as we continue to discover how new intelligence impacts health and life sciences in Atlantic Canada.”
This year’s conference will feature two keynote speakers. Dr. Corinna Lathan, ranked as one of the ‘Top 100 World Innovators’ by MIT Technology Review, will be delivering the evening keynote on the impact of technology on health at 6:00 pm on Wednesday, November 7, 2018.
“As Atlantic Canada’s health and life sciences sector continues to expand, we seek to evolve the topics we choose to feature at BioPort,” Scott Moffitt, Executive Director of BioNova told us.
“Our sessions explore how embracing disruptive technologies, like artificial intelligence, and uncovering emerging markets, like the value of natural products, present opportunities to grow our sector.”
New to this year’s program is BIC Junior, a pitch competition for students that aims to cultivate the next generation of health and life sciences innovators. Emergence director, Martin Yuill, is a judge for the BIC Junior pitch competition.
Our friends at Natural Products Canada have partnered with BioNova to present a new Emerging Natural Products Session at BioPort. Stephen Ball, NPC’s Regional Director for the four Atlantic provinces, will moderate a line-up of industry and academic leaders on the topics of medical cannabis and focusing the region’s natural product market opportunities. Representatives from Emergence client, DoseCann, Cape Breton University, Panang Pharmaceuticals and others will help navigate the landscape of these two timely topics.
Details of the conference program and schedule can be found at www.bioportatlantic.ca.